‘The increase in the rate of the costly, serious procedure with no evidence of survival advantage comes, paradoxically, at the same time of greater focus on quality and worth in cancer care,’ said study leader Dr. Ahmedin Jemal, vice president of health insurance and surveillance services research in the American Cancer Culture. The study included a lot more than 6,300 guys who had surgery for cancer in one breast. Their surgeries occurred between 2004 and 2011. The %age of males who also experienced their cancer-free breasts removed rose from 3 % in 2004 to 5.6 % in 2011, the study found.The EVAR 1 investigators attributed loss of the perioperative survival advantage within their study to late ruptures after endovascular fix.3 Inside our study, there were only three fatal aneurysm ruptures, rendering this explanation inadequate. Furthermore, if lack of the perioperative survival benefit were because of late deaths attributable to endovascular repair, one would anticipate the survival curves to ultimately cross and the endovascular-restoration group to have even worse long-term survival, but there is no proof for this in virtually any of the three research.